Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZP120 in acute or sub-acute decompensated chronic heart failure
NCT00283361Phase 2Terminated
- Sponsor
- Zealand Pharma
- Start
- Jan 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute decompensated heart failure (ADHF) comparing ZP120 Arm with Placebo Arm (2 arms). Primary endpoint: Change in dyspnea severity. Started Jan 2006; status: terminated.
02
Drugs
SER-100
03
Conditions
acute decompensated heart failure (ADHF)
Beyond the preview
Go deeper on NCT00283361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283361.